February 9, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Inovalon Holdings Inc (NASDAQ:INOV) shares over potential securities laws violations by Inovalon Holdings and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Inovalon Holdings Inc (NASDAQ:INOV) concerning whether a series of statements by Inovalon Holdings regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Bowie, MD based Inovalon Holdings, Inc. is a technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings Inc went public in early February 2015 and shares reached as high as $31.75 per share in late February 2015.

In late March 2015 Inovalon Holdings Inc reported its fourth quarter and full year 2014 results.
Inovalon Holdings Inc reported that its annual Total Revenue rose from $295.80 million in 2013 to $361.54 million in 2014 and that its Net Income increased from $32.72 million in 2013 to $65.35 million in 2014.

Since then shares of Inovalon Holdings Inc (NASDAQ:INOV) declined to as low as $15.12 per share on January 21, 2016.